Abbott has recalled a small number of Freestyle Libre 3 sensors distributed in the U.S. in the first half of May, the company said Wednesday. Internal testing found a subset of three lots of the ...

A small number of sensors that read blood sugar levels continuously may give incorrect info. Here's how to check your FreeStyle Libre 3 for a replacement.

That clearance gives users of the FreeStyle Libre 3—Abbott’s newest CGM, which itself was cleared by the FDA last May —the option to decide whether they’d prefer to use either the Abbott ...

The US Food and Drug Administration (FDA) has cleared the Abbott Libre 2 and 3 continuous glucose monitoring (CGM) sensors for use during most imaging procedures, including MRI under certain ...

Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus* sensor, is now available to Canadians living with diabetes ...

FreeStyle Libre is a continuous glucose monitoring (CGM) system. It uses a sensor to read and check a person’s glucose levels. People with diabetes can use FreeStyle Libre to help manage the ...

The FDA cleared the FreeStyle Libre 3 system, Abbott said Tuesday, and the company will begin rolling out the glucose sensor to participating pharmacies later this year.

Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus* sensor, is now available to Canadians living with diabetes.